Cerebral aspergillus carries a high mortality in immunocompromised patients
. However, favorable outcome can be achieve by the prolonged use of antifun
gal agents and the maintenance of adequate drug levels. The authors report
a 2-year-old girl who developed an aspergillus brain abscess during treatme
nt for acute lymphoblastic leukemia. Predisposing factors for the fungal in
fection and details of the antifungal therapy are described. Prolonged trea
tment with AmBisome and 5-flucytosine successfully eradicated the lesion, b
ut the girl's antileukemic therapy was compromised due to the infection. Sh
e developed a central nervous system and bone marrow relapse 9 and 15 month
s, respectively, after the initial presentation. The report emphasizes the
need for further consideration of effective, long-term antifungal prophylax
is and a careful balance between aggressive treatment for severe infection
and antileukemic therapy.